The parties intend to finalize and execute the definitive license agreement in the coming months, pending necessary approvals from Northstrive's head licensor for certain intellectual property rights related to EL-22. NEWPORT BEACH, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. ("Northstrive"), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the "Company," "PMGC," "we," or "our"), today announced the signing of a binding term sheet with Modulant Biosciences LLC ("Modulant"). This ...